These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36000937)

  • 1. Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing.
    Siripipattanamongkol N; Rattanasak S; Taiyaitieng C; Inthajak Y; Kuawatcharawong N; Sukasem C; Tempark T
    Pediatr Dermatol; 2022 Jul; 39(4):601-605. PubMed ID: 36000937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on "Toxic epidermal necrolysis (TEN) after first dose of Pfizer (BNT162b2) vaccination and pharmacogenomic-based-point-care support: First case report in pediatric and review of literature".
    Martinez-Cabriales SA; Shear NH
    Pediatr Dermatol; 2022 Jul; 39(4):671-672. PubMed ID: 36000935
    [No Abstract]   [Full Text] [Related]  

  • 3. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap After the Third Dose of BNT162b2 mRNA COVID-19 Vaccination and Literature Review.
    Jue MS; Joh HC; Kim SH; Ko JY
    Dermatitis; 2023; 34(2):158-159. PubMed ID: 36716204
    [No Abstract]   [Full Text] [Related]  

  • 4. An Unusual Presentation Of Steven-Johnson Syndrome After Bnt162b2 Covid-19 Vaccination.
    Patel R; Lu V
    J Ayub Med Coll Abbottabad; 2023; 35(1):180-181. PubMed ID: 36849405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An extremely rare mucocutaneous adverse reaction following COVID-19 vaccination: Toxic epidermal necrolysis.
    Mardani M; Mardani S; Asadi Kani Z; Hakamifard A
    Dermatol Ther; 2022 May; 35(5):e15416. PubMed ID: 35238119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Padniewski JJ; Jacobson-Dunlop E; Albadri S; Hylwa S
    Int J Dermatol; 2022 Aug; 61(8):923-929. PubMed ID: 35398905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The seven-fold rise in incidence of Stevens-Johnson syndrome & toxic epidermal necrolysis: Associations with COVID-19 and the vaccine.
    Stanley EA; Zhang L; O'Hara J; Haertsch P; Maitz P
    Burns; 2024 Feb; 50(1):87-92. PubMed ID: 37730480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of treatment with plasma exchange therapy in two pediatric toxic epidermal necrolysis cases related to COVID-19.
    Varol F; Can YY; Sahin E; Durak C; Kilic A; Sahin C; Gursoy F; Akin T
    J Clin Apher; 2022 Oct; 37(5):516-521. PubMed ID: 35792366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Background rates for severe cutaneous reactions in the US: Contextual support for safety assessment of COVID-19 vaccines and novel biologics.
    Gubernot D; Menis M; Whitaker B
    Vaccine; 2023 Nov; 41(47):6922-6929. PubMed ID: 37891051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine.
    Luo A; Oakley A
    Australas J Dermatol; 2022 Aug; 63(3):e247-e250. PubMed ID: 35607272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parsonage-Turner Syndrome After COVID-19 Vaccination in a Child.
    Cassart EM; Vilas DR; Abe R; Cavanilles-Walker JM
    J Am Acad Orthop Surg Glob Res Rev; 2023 Mar; 7(3):. PubMed ID: 36893168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
    Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Hugueley B; Thompson D; Gee J; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1047-1051. PubMed ID: 35980875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination.
    Rose C; Apgar R; Green M
    J Cutan Pathol; 2022 Nov; 49(11):943-946. PubMed ID: 35754159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination.
    Kherlopian A; Zhao C; Ge L; Forward E; Fischer G
    Australas J Dermatol; 2022 Feb; 63(1):e93-e95. PubMed ID: 34751429
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccine.
    Sapsford S; Wood B
    N Z Med J; 2022 Oct; 135(1564):72-76. PubMed ID: 36302245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythema Multiforme Reactions Following Pfizer/BioNTech (Tozinameran) Vaccination: Two Case-Reports with Positive Rechallenge and Review of the Literature.
    Charfi O; Lakhoua G; Berrim K; Kastalli S; Badri T; Aouinti I; Daghfous R; Zaiem A; Aidli SE
    Curr Drug Saf; 2024; 19(4):465-468. PubMed ID: 37489779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk.
    Shavit R; Maoz-Segal R; Iancovici-Kidon M; Offengenden I; Haj Yahia S; Machnes Maayan D; Lifshitz-Tunitsky Y; Niznik S; Frizinsky S; Deutch M; Elbaz E; Genaim H; Rahav G; Levy I; Belkin A; Regev-Yochay G; Afek A; Agmon-Levin N
    JAMA Netw Open; 2021 Aug; 4(8):e2122255. PubMed ID: 34463744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system.
    Ball R; Ball LK; Wise RP; Braun MM; Beeler JA; Salive ME
    Pediatr Infect Dis J; 2001 Feb; 20(2):219-23. PubMed ID: 11224848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.